abstract |
The present invention provides a process for the preparation of stable, crystalline cephalosporin intermediates of the formula ##STR1## wherein X is HI, HCl or H 2 SO 4 which are substantially free of the Δ 2 isomer, and which are convertible into broad-spectrum cephalosporin antibiotics. |